Ronald Blue Trust, Inc. Castle Biosciences Inc Transaction History
Ronald Blue Trust, Inc.
- $7.01 Billion
- Q1 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 956 shares of CSTL stock, worth $20,324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
956
Previous 956
-0.0%
Holding current value
$20,324
Previous $16,000
31.25%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CSTL
# of Institutions
162Shares Held
25.3MCall Options Held
82.2KPut Options Held
150K-
Black Rock Inc. New York, NY2.6MShares$55.2 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.55MShares$54.2 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.63MShares$34.6 Million1.3% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.53MShares$32.6 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.49MShares$31.8 Million0.0% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $559M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...